Pliant Therapeutics, Inc. revenue breakdown overview

Pliant Therapeutics, Inc. revenue for the last year amounted to 1.58 M USD, the most of which — 1.58 M USD — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 9.69 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Pliant Therapeutics, Inc. 1.58 M USD, and the year before that — 9.69 M USD.